HERA-GITRL activates T cells and promotes anti-tumor efficacy independent of FcγR-binding functionality

Overview of attention for article published in Journal for Immunotherapy of Cancer, July 2019

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#41 of 1,212)
High Attention Score compared to outputs of the same age (96th percentile)

Mentioned by

news: 8 news outlets

twitter: 9 tweeters

Citations

dimensions_citation: 12 Dimensions

Readers on

mendeley: 18 Mendeley

Summary News Twitter Dimensions citations

So far, Altmetric has seen 9 news stories from 8 outlets.

News story from Finanz Nachrichten on Tuesday 23 July 2019

Finanz Nachrichten, 23 Jul 2019

News story from Finanz Nachrichten on Tuesday 23 July 2019

Finanz Nachrichten, 23 Jul 2019

Excellent Preclinical Efficacy Data of Apogenix' HERA-GITRL Published in Journal for ImmunoTherapy of Cancer

Digital Journal, 23 Jul 2019

HERA-GITRL Shows Strong Single-Agent Anti-Tumor Activity in Vitro and in Vivo and is Superior to Bivalent Clinical Benchmark…

Excellent Preclinical Efficacy Data of

Direkt Broker , 23 Jul 2019

Apogenix' HERA-GITRL Published in Journal for ImmunoTherapy of Cancer HERA-GITRL Shows Strong Single-Agent Anti-Tumor Activity…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity, including 5 additional news stories.